Treatment of anemia with Aranesp™ (darbepoetin alfa) improves health related quality of life (HRQOL) in patients with chronic kidney disease (CKD).

被引：0
|
作者：
Thadhani, R
Cheriyan, R
Brenner, R
Ford, J
Powers, K
Rahman, SN
机构：
[1] Univ Texas, Hlth Sci Ctr, Houston, TX USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Virginia Nephrol Grp, Fairfax, VA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：637A / 637A
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics (PK) of Aranesp® (darbepoetin alfa) in patients with chronic kidney disease (CKD)
    Padhi, D
    Jang, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V255 - V255
  • [2] HRQOL improvements in anemic CKD patients treated with darbepoetin alfa (Aranesp™)
    Ruhman, SN
    Heifner, KJ
    Fadem, SZ
    Melvor, ME
    Brenner, RM
    Powers, KM
    Ford, JM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A27 - A27
  • [3] Anemia management preferences in chronic kidney disease (CKD) patients converted to oncemonthly (QM) ARANESP® (darbepoetin alfa)
    Vainer, A
    Hoggard, J
    Koenig, K
    Prathikanti, R
    Scarlata, D
    Globe, D
    Audhya, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A54 - A54
  • [4] The CHOIR study: Health-related quality of life (HRQOL) in patients with anemia of chronic kidney disease (CKD).
    Singh, AK
    Bhaduri, S
    Day, B
    Klausner, M
    Corwin, M
    Reddan, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 456A - 457A
  • [5] Aranesp® improves health related quality of life in CKD patients with chronic renal insufficiency.
    Geronemus, R
    Pettitt, D
    Robbins, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 794A - 794A
  • [6] Aranesp® (darbepoetin alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease (CKD).
    Walczyk, M
    Agarwal, A
    Ling, B
    Carroll, W
    Liu, W
    Brenner, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A38 - A38
  • [7] Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease
    Bradley A. Warady
    Mazen Y. Arar
    Gary Lerner
    Arline M. Nakanishi
    Catherine Stehman-Breen
    Pediatric Nephrology, 2006, 21 : 1144 - 1152
  • [8] Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease
    Warady, Bradley A.
    Arar, Mazen Y.
    Lerner, Gary
    Nakanishi, Arline M.
    Stehman-Breen, Catherine
    PEDIATRIC NEPHROLOGY, 2006, 21 (08) : 1144 - 1152
  • [9] Aranesp® (Darbepoetin alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease (CKD).
    Agarwal, A
    Ling, B
    Walczyk, M
    Carroll, W
    Liu, W
    Brenner, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A15 - A15
  • [10] Low health-realted quality-of-life (HRQOL) scores in patients with anemia and chronic kidney disease (CKD)
    Heifner, JK
    Shapiro, WB
    Navarro, JO
    Woolley, JM
    Ford, JM
    Connolly-Giwa, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A21 - A21
12345